Advancio Talks Season 2 – Episode 20 with – Adam Watson

Host Carlos Ponce sits down LIVE with Adam Watson, CEO of MeCo Diagnostics, to explore how cutting-edge biotech and technology are solving a crisis most people don’t see coming: cancer isn’t just destroying lives, it’s crushing families financially, long after patients are gone. Adam’s team developed the MeCo Score, the first clinically validated predictive biomarker showing a 62% reduction in cancer recurrence at a fraction of traditional treatment costs. This is about real innovation validated across nearly 4,000 patients at institutions like Cleveland Clinic and Mayo Clinic. If you care about where healthcare and technology intersect to solve actual human problems, this conversation is for you. Watch live, ask questions, and join a discussion that goes beyond the hype.